CENTESSA PHARMACEUTICALS-ADR (CNTA) Institutional Ownership and Insiders Activity

CENTESSA PHARMACEUTICALS-ADR (CNTA) is widely held by institutional investors, with 4 firms reporting positions valued at approximately $140.08M based on SEC Form 13F filings for the quarter ended March 31, 2026.

Janus Henderson Group Plc is the largest disclosed holder, reporting approximately $138.74M in CNTA holdings in its latest filing.

Institutional ownership remains highly concentrated, with Janus Henderson Group Plc representing the majority of disclosed value.

Recent insider activity includes 24 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.